Department of Health and Human Services (DHHS)

Federal Announcements

Biden-Harris Administration Awards $600 Million to Bolster US Manufacturing of COVID-19 Tests and Announces the Re-Opening of COVIDTests.gov

September 20, 2023 | Department of Health and Human Services (DHHS) | COVID-19

The U.S. Department of Health and Human Services invested $600 million across 12 domestic COVID-19 test manufacturers and the reopening of COVIDTests.gov to deliver COVID-19 tests for free to households across the country. These investments in U.S. manufacturing will improve preparedness for COVID-19 and other pandemic threats of the future, strengthen the nation’s capacity to manufacture tests, and secure approximately 200 million new over-the-counter COVID-19 tests for future federal use.

Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics

August 22, 2023 | Department of Health and Human Services (DHHS) | COVID-19, Medical and Pharmaceutical

The U.S. Department of Health and Human Services awarded more than $1.4 billion for Project NextGen to support the development of a new generation of tools and technologies to protect against COVID-19. The awards follow extensive coordination with industry partners and include support for clinical trials that will enable the rapid development of more effective and longer-lasting coronavirus vaccines, a new monoclonal antibody and transformative technologies to streamline manufacturing processes.

Fact Sheet: HHS Announces ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured

April 18, 2023 | Department of Health and Human Services (DHHS) | COVID-19, Medical and Pharmaceutical

HHS is announcing the “HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program’ to maintain broad access to COVID-19 vaccines for millions of uninsured Americans. The program will create a unique $1.1 billion public-private partnership to help maintain uninsured individuals’ access to COVID-19 care at their local pharmacies, through existing public health infrastructure, and at their local health centers.

Biomedical Advanced Research and Development Authority – Pharmaceutical Countermeasures Infrastructure (PCI)

Agency:
Department of Health and Human Services (DHHS)

Topics:
Biomedical, Healthcare, Research and Development (R&D)

A strong, committed partnership between industry and the federal government is vital when responding to a public health emergency. Through the work of its three programs, PCI partners with industry to strengthen and enhance the nation’s ability to manufacture, distribute, and administer life-saving vaccines and therapeutics during a public health emergency.

Visit
Manufacturing USA

Agencies:
Department of Agriculture (USDA), Department of Commerce (DOC), Department of Defense (DoD), Department of Education (ED), Department of Energy (DOE), Department of Health and Human Services (DHHS), Department of Labor (DOL), National Aeronautics and Space Administration (NASA), National Institute of Standards and Technology (NIST), National Science Foundation (NSF)

Topics:
Advanced Manufacturing, Clean Energy, COVID-19, Cybersecurity, Industrial Commons, Industry 4.0, Supply Chain, Technology, Workforce

Manufacturing USA was created in 2014 to secure U.S. global leadership in advanced manufacturing by connecting people, ideas, and technology. Manufacturing USA institutes convene business competitors, academic institutions, and other stakeholders to test applications of new technology, create new products, reduce cost and risk, and enable the manufacturing workforce with the skills of the future. Key initiatives include Future Manufacturing Supply Chains Manufacturing, Manufacturing Workforce Development, Advanced Manufacturing Technology Leadership, Covid 19 Manufacturing Recovery, and Clean Energy Manufacturing.

Visit
Materials Genome Initiative

Agencies:
Department of Defense (DoD), Department of Energy (DOE), Department of Health and Human Services (DHHS), Department of the Interior (DOI), National Institute of Standards and Technology (NIST), National Institutes of Health (NIH), National Science Foundation (NSF)

Topics:
Advanced Manufacturing, Research and Development (R&D), Workforce

The Materials Genome Initiative is a federal multi-agency initiative for discovering, manufacturing, and deploying advanced materials twice as fast and at a fraction of the cost compared to traditional methods. The initiative creates policy, resources, and infrastructure to support U.S. institutions in the adoption of methods for accelerating materials development.

Visit
National Biopharmaceutical Manufacturing Preparedness Consortium (BioMap-Consortium)

Agency:
Department of Health and Human Services (DHHS)

Topics:
Biomedical, Healthcare, Research and Development (R&D), Supply Chain, Technology

The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) supports the Biomedical Advanced Research and Development Authority (BARDA) and is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, developers of innovative manufacturing technologies, and suppliers of fill finish services. This consortium seeks to expand the industrial and manufacturing base for medical countermeasures to include the requisite capabilities, flexibilities, and strategies to secure needed medical supplies to meet the nation’s public health preparedness and response requirements.

Visit

Department of Health and Human Services (DHHS)

Federal Announcements

Biden-Harris Administration Awards $600 Million to Bolster US Manufacturing of COVID-19 Tests and Announces the Re-Opening of COVIDTests.gov

Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics

Fact Sheet: HHS Announces ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured

Related Programs

Biomedical Advanced Research and Development Authority – Pharmaceutical Countermeasures Infrastructure (PCI)

Manufacturing USA

Materials Genome Initiative

National Biopharmaceutical Manufacturing Preparedness Consortium (BioMap-Consortium)

For General Information

MEP Headquarters